Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research

Current Issue

January-February 2026 (Vol. 23 Issue 1) Table of Contents
Cancer Genomics - Proteomics: 23 (1)

Issue highlights

  • Mutational Spectrum of T-Cell Large Granular Lymphocytic Leukemia: Insights From the AACR Project GENIE Consortium
  • Exosomes Transfer ST6GAL1-mediated Therapeutic Resistance in Rectal Cancer Cells
  • RUNX2 Represses the EWS-FLI1-mediated Transcription in Ewing’s Sarcoma Cells
  • Prognostic Implications of Exosomal miRNA Networks Regulating TGFβ1-induced Epithelial–Mesenchymal Transition Signature in Oral Squamous Cell Carcinoma
  • Comparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast Cancer

 


 

⚠️ Important Notice: Fraudulent Emails

We have been informed of fraudulent emails impersonating IIAR editors and requesting financial assistance or bank transfers. These messages do NOT come from us.

Please note that the ONLY official IIAR email domains are:

  • @iiar-anticancer.org
  • @iiar-submissions.com

If you receive any suspicious message from another address—especially requests involving money—do not respond. Report the message as spam/phishing and contact us directly through our official email addresses.

Thank you for your vigilance.

Featured Articles

  • Low Levels of Microsatellite Instability at Simple Repeated Sequences Commonly Occur in Human...
    September 04, 2017
  • The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan
    April 25, 2018
  • Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor...
    October 28, 2019
  • WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma
    December 26, 2015
  • Data-driven Analysis of TRP Channels in Cancer: Linking Variation in Gene Expression to Clinical...
    December 26, 2015
  • ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and...
    March 01, 2018

Latest Articles

  • Open Access
    Comparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast Cancer
    FANG-MING CHEN, CHUNG-LIANG LI, MEI-REN PAN, YUN-CIAN HUANG, LI-JU HUANG, SIN-HUA MOI, SHU-JYUAN CHANG, PING-FU YANG, CHIEH-NI KAO, JUNG-YU KAN, LI-KUN KO, HIDENOBU TAKAHASHI, CHIA-YU KUO, SHEN-LIANG SHIH, MING-FENG HOU, YI-HSIUNG LIN and CHI-WEN LUO
    Cancer Genomics & Proteomics January 2026, 23 (1) 66-80; DOI: https://doi.org/10.21873/cgp.20561
  • Open Access
    Mechanistic Insights into Threonine Tyrosine Kinase Mediated Cell Cycle Regulation in Triple-negative Breast Cancer
    SIYA TANG, JIAYU ZHENG, YALIN ZHANG, LI ZENG, JINGJING WANG, SHUNSHUN ZHANG, YOUYOU CHEN, QINAN YIN and XUEWEI ZHENG
    Cancer Genomics & Proteomics January 2026, 23 (1) 93-108; DOI: https://doi.org/10.21873/cgp.20563
  • Open Access
    Exosomes Transfer ST6GAL1-mediated Therapeutic Resistance in Rectal Cancer Cells
    JEREMIE M. P. LEVER, REGINA K. IRWIN, VIVEK SOMASUNDARAM, YUWEI SONG, CHANDLER M. MCLEOD, MARY SMITHSON, GREGORY WILLIAMS, ZECHEN CHONG and KARIN M. HARDIMAN
    Cancer Genomics & Proteomics January 2026, 23 (1) 12-26; DOI: https://doi.org/10.21873/cgp.20558
  • Open Access
    Prognostic Implications of Exosomal miRNA Networks Regulating TGFβ1-induced Epithelial–Mesenchymal Transition Signature in Oral Squamous Cell Carcinoma
    MINJEONG KIM, SU IL KIM, YOUNG-GYU EUN, NAKWON CHOI, JUNBEOM KIM and YOUNG CHAN LEE
    Cancer Genomics & Proteomics January 2026, 23 (1) 50-65; DOI: https://doi.org/10.21873/cgp.20560
  • Open Access
    Myxoid Pleomorphic Liposarcoma: A Review and Update
    JUN NISHIO, SHIZUHIDE NAKAYAMA and MIKIKO AOKI
    Cancer Genomics & Proteomics January 2026, 23 (1) 1-11; DOI: https://doi.org/10.21873/cgp.20557
  • Open Access
    Low CTDNEP1 Expression Predicts Poor Prognosis and Is Associated With Immune Modulation in Pancreatic Cancer
    MAYUKA NII and TADAYOSHI HAYATA
    Cancer Genomics & Proteomics January 2026, 23 (1) 144-154; DOI: https://doi.org/10.21873/cgp.20567
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile

Access CGP at your Mobile Device

Now you can access the entire contents of Cancer Genomics & Proteomics at your Android or iOS device with our newly designed mobile app, freely available through Google Play and App Store.

Visit the official website of Cancer Genomics & Proteomics.
Back to top
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire